🔬PostEra Accelerates Drug Discovery with $1B in AI Partnerships
PostEra's AI-first approach to drug discovery is shaking up the biotech industry
TL;DR
PostEra, an AI-first biotech company, has secured over $1 billion in partnerships, including deals with Pfizer and Amgen. The company uses Proton, its AI platform, to accelerate drug discovery in areas like Women's Health and Fertility.
PostEra, an AI-first biotech company, has secured over $1 billion in partnerships, including four multi-year agreements with Pfizer and Amgen. This funding will support the development of Proton, an AI platform for medicinal chemistry that accelerates drug discovery. PostEra's pipeline includes projects focused on Women's Health and Fertility, with multiple clinical candidates already nominated. The company's minimalist organizational structure and focus on agentic research systems make it a unique player in the biotech industry. The role involves developing machine learning methods that can rapidly adapt to new drug discovery problems from limited labeled data, building foundation models from PostEra's proprietary multimodal data, and helping drive the full research loop. The salary range is $200,000 to $300,000, with an equity range of 0.05% to 0.1%.
Key Points
PostEra has secured over $1 billion in AI partnerships, including four multi-year agreements with Pfizer and Amgen.
PostEra's Proton platform accelerates drug discovery in areas like Women's Health and Fertility.
PostEra's pipeline includes multiple clinical candidates nominated using Proton.
The role involves developing machine learning methods that can rapidly adapt to new drug discovery problems from limited labeled data.
The salary range for the role is $200,000 to $300,000, with an equity range of 0.05% to 0.1%.
Why It Matters
If you're working in drug discovery, PostEra's AI-first approach could revolutionize how you approach new projects. The company's Proton platform, which accelerates drug discovery in areas like Women's Health and Fertility, has already secured over $1 billion in partnerships with major pharmaceutical companies. This funding will support the development of new AI-driven methods for drug discovery, making it a key player in the biotech industry.
Comments
Be the first to comment
Enjoyed this article?
Get it daily. 7am. Free. Reads in 5 minutes.
Join 3,568 builders reading daily.